Jin Aoming, Wang Mengxing, Chen Weiqi, Yan Hongyi, Xiang Xianglong, Pan Yuesong
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Front Cardiovasc Med. 2022 Jul 4;9:891148. doi: 10.3389/fcvm.2022.891148. eCollection 2022.
Observational studies indicated that cholesterol efflux capacity (CEC) of high-density lipoprotein (HDL) is inversely associated with cardiovascular events, independently of the HDL cholesterol concentration. The aim of the study is to examine the casual relevance of CEC for coronary artery disease (CAD) and myocardial infarction (MI), and compare it with that for ischemic stroke and its subtypes using a Mendelian randomization approach.
We performed a 2-sample Mendelian randomization to estimate the casual relationship of CEC with the risk of CAD, MI, and ischemic stroke. A CEC-related genetic variant (rs141622900) and other five genetic variants were used as the instrumental variables. Association of genetic variants with CAD were estimated in a GWAS involving 60,801 CAD cases and 123,504 controls. They were then compared with the associations of these variants with ischemic stroke and its subtypes (large vessel, small vessel, and cardioembolic) involving 40,585 ischemic stroke cases and 406,111 controls.
Using the SNP of rs141622900 as the instrument, a 1-SD increase in CEC was associated with 45% lower risk for CAD (odds ratio [OR] 0.55, 95% confidence interval [CI] 0.44-0.69, < 0.001) and 33% lower risk for MI (odds ratio [OR] 0.67, 95% CI 0.52-0.87, = 0.002). By contrast, the causal effect of CEC was much weaker for ischemic stroke (odds ratio [OR] 0.79, 95% CI 0.64-0.97, = 0.02; for heterogeneity = 0.03) and, in particular, for cardioembolic stroke ( for heterogeneity = 0.006) when compared with that for CAD. Results using five genetic variants as the instrument also indicated consistently weaker effects on ischemic stroke than on CAD.
Genetic predicted higher CEC may be associated with decreased risk of CAD. However, the casual association of CEC with ischemic stroke and specific subtypes would need to be validated in further Mendelian randomization studies.
观察性研究表明,高密度脂蛋白(HDL)的胆固醇流出能力(CEC)与心血管事件呈负相关,且独立于HDL胆固醇浓度。本研究的目的是使用孟德尔随机化方法检验CEC与冠状动脉疾病(CAD)和心肌梗死(MI)之间的因果关系,并将其与缺血性中风及其亚型的因果关系进行比较。
我们进行了一项两样本孟德尔随机化研究,以估计CEC与CAD、MI和缺血性中风风险之间的因果关系。一个与CEC相关的基因变异(rs141622900)和其他五个基因变异被用作工具变量。在一项涉及60801例CAD病例和123504例对照的全基因组关联研究(GWAS)中估计基因变异与CAD的关联。然后将它们与这些变异与缺血性中风及其亚型(大血管、小血管和心源性栓塞)的关联进行比较,缺血性中风及其亚型涉及40585例缺血性中风病例和406111例对照。
以rs141622900的单核苷酸多态性(SNP)为工具,CEC每增加1个标准差,CAD风险降低45%(比值比[OR]0.55,95%置信区间[CI]0.44 - 0.69,P < 0.